In-hospital initiation | Therapies at discharge |
ACEI/ARB for HFrEF | ACEI/ARB for HFrEF |
β-blockers for HFrEF | β-blockers for HFrEF |
Aldosterone antagonist for HFrEF | Aldosterone antagonist for HFrEF |
Anticoagulation for atrial fibrillation | Risk intervention |
Evaluation of left ventricular systolic function | |
CRT therapy in eligible patients | |
ICD therapy in eligible patients |
ACEI, ACE inhibitor; ARB, angiotensin receptor blocker; CRT, cardiac resynchronisation therapy; HFrEF, heart failure with reduced ejection fraction; ICD, implantable cardioverter defibrillator.
*Performance measures will be calculated for individuals with clinical indications according to ACC/AHA guidelines and without documented contraindications.